New Cancer Meds to Fill Half of Israel’s Subsidized Drug Basket for 2017

The additions also include drugs for lung disease, heart disease, vascular disease, diabetes and neurological diseases.

comments Print
More than 80 new drugs and technologies – at a cost of 470 million shekels ($122 million) – will be added to Israel’s “health basket” of subsidized treatments this year, including 230 million shekels ($60...